NCT02526095招募中不适用
National Oesophageal and Gastric Carcinomas Data Base Construction: the FREGAT (French EsoGastric Tumours) Data Base
University Hospital, Lille33 个研究点 分布在 1 个国家目标入组 15,000 人开始时间: 2014年6月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 15,000
- 试验地点
- 33
- 主要终点
- DIsease free survival
研究概览
简要总结
This retrospective study aims at evaluating the outcomes of gastrointestinal stromal tumor after surgery.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with
- •esophageal cancer, gastric or gastroesophageal junction diagnosed biopsy , regardless of the subtype of cancer, tumor stage or treatment envisaged.
- •Naive treatment for this cancer,
- •Naive treatment for this cancer , failing that received neoadjuvant treatment ,
- •Male or female ≥ 18 years.
- •social protection scheme .
- •sign a free and informed consent for blood sampling , the different questionnaires and the collection of patient information.
排除标准
- •Male or female aged ( e) under 18 years.
- •Private person of liberty or under supervision (including guardianship ) .
- •People who do not speak French.
- •Major Nobody unable to consent .
- •Patient FREGAT already included in the base.
- •Patient Refusal .
结局指标
主要结局
DIsease free survival
时间窗: 5 year disease free survival
次要结局
- overall survival(5 year overall survival)
- recurrence rate(5 year recurrence rate)
- Total number of patients with complications(from the time between inclusion and occurrence of the event, for the duration of 3 years)
- Total number of complications(from the time between inclusion and occurrence of the event, for the duration of 3 years)
- Death(from the time between inclusion and occurrence of the event, for the duration of 3 years)
研究者
研究点 (33)
Loading locations...
相似试验
已完成
不适用
Clinical Outcome of Female Non-gastric Gastrointestinal Stromal TumorGastrointestinal Stromal TumorNCT04256226Far Eastern Memorial Hospital26
已完成
不适用
Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)GISTNCT04599660Italian Sarcoma Group700
终止
3 期
Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal TumorsGastrointestinal Stromal TumorNCT00372567Pfizer69
Unknown
不适用
the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal TumorGastrointestinal Stromal TumorNCT02763748First Affiliated Hospital Xi'an Jiaotong University120
进行中（未招募）
1 期
ocalized gastrointestinal stromal tumors (GIST): an exploratory open-label, multicenter, single-arm phase II study to evaluate the efficacy of 2 years of adjuvant nilotinib treatment following at least 1 year of adjuvant imatinib mesylatelocalized gastrointestinal stromal tumors (GIST)MedDRA version: 13.1Level: LLTClassification code 10062427Term: Gastrointestinal stromal tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-022713-26-DEovartis Pharma GmbH